- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04949217
An Exploratory Randomized Controlled Study of Arthroscopic Inlay Bristow Procedure for Recurrent Anterior Shoulder Dislocation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim: To compare the clinical and radiographic outcomes following the arthroscopic Chinese Unique Inlay Bristow (Cuistow) procedure and the arthroscopic Bristow procedure.
Background: The Cuistow procedure is a modified Bristow surgery in which a Mortise and Tenon structure was added to the contact surface between the coracoid tip and the glenoid. In previous retrospective study, patients received Cuistow procedure have satisfying clinical performance and excellent postoperative bone healing rate (96.1%). However, no prospective randomized controlled trial was performed.
Methods: 70 patients with recurrent anterior shoulder instability were included and randomized to either an arthroscopic Cuistow procedure or arthroscopic Bristow procedure. Radiological evaluations with 3D CT scan were performed preoperatively, immediately after the operation, and postoperatively at three months and during the final follow-up (more than 2 years). Clinical assessment for a minimum of 24 months including the 10-point visual analog scale for pain and subjective instability, University of California at Los Angeles scoring system (UCLA score), American Shoulder and Elbow Surgeons score (ASES score), ROWE score, Subjective Shoulder Value (SSV) and active range of motion were completed by independent observers and analyzed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Recurrent anterior shoulder instability based on medical history, physical examination, and radiological results.
- A glenoid defect ≥10% but <25%
- Participation in high-demand (collision and overhead) sports combined with the presence of a glenoid defect <25% of the glenoid or without defect
- Failure after Bankart repair
Exclusion Criteria:
- Multi-directional shoulder instability
- Uncontrolled epilepsy
- History of receiving Bristow-Latarjet procedure.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Inlay Bristow Group
Inlay Bristow procedure
|
A modified Bristow procedure
Other Names:
|
|
Active Comparator: Onlay Bristow Group
Onlay Bristow procedure
|
Traditional Bristow procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ASES score
Time Frame: 2-year postoperatively
|
The ASES score (Michener 2002) is a 10-item measure of shoulder pain and function.
Pain is assessed on a 10-cm visual analog scale (VAS) and accounts for 50% of the total score.
The remaining 50% of the score is determined by the responses to 10 4-point Likert-scale questions related to physical function.
|
2-year postoperatively
|
|
Bone union rate
Time Frame: 3-month postoperatily
|
Bone healing was observed in 3D-CT.
The bone healing rate was obtained by dividing the number of people who achieved bone healing by the total number of people
|
3-month postoperatily
|
|
Bone union rate
Time Frame: 2-year postoperatively
|
Bone healing was observed in 3DCT.
The bone healing rate was obtained by dividing the number of people who achieved bone healing by the total number of people
|
2-year postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS for pain score
Time Frame: 2-year postoperatively
|
The visual analog scale (VAS) for pain score is the most commonly used to describe pain levels in patients, ranging from 0 to 10, with a higher score indicating more intense pain.
|
2-year postoperatively
|
|
Active shoulder ranges of motion
Time Frame: 2-year postoperatively
|
internal rotation at the side, and external and internal rotation at 90° of abduction
|
2-year postoperatively
|
|
dislocation rate
Time Frame: 2-year postoperatively
|
The dislocation rate was obtained by dividing the number of people who dislocated postopratively by the total number of people
|
2-year postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Guoqing Cui, Peking University Third Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M2021039
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Dislocation
-
Keller Army Community HospitalCompletedSurgery | Anterior Shoulder Dislocation | Shoulder Subluxation | Recurrent Shoulder DislocationUnited States
-
University of PittsburghDuke UniversityRecruitingShoulder Dislocation | Anterior Shoulder Dislocation | Glenohumeral DislocationUnited States
-
Peking University Third HospitalCompletedShoulder; Dislocation, ChronicChina
-
Istituto Ortopedico RizzoliCompletedShoulder Instability | Anterior Shoulder Dislocation | Bone DefectsItaly
-
Alon RabinMedical Corps, Israel Defense ForceRecruiting
-
Centre Hospitalier Universitaire de NiceRecruitingAnterior Shoulder DislocationFrance
-
Copenhagen University Hospital, HvidovreCompletedAnterior Shoulder Dislocation
-
Tel-Aviv Sourasky Medical CenterUnknownAnterior Shoulder Dislocation
-
National Taiwan University HospitalUnknownShoulder Anterior DislocationTaiwan
-
Unity Health TorontoTerminatedPrimary Anterior Shoulder DislocationCanada
Clinical Trials on Inlay Bristow
-
Peking University Third HospitalCompleted
-
Peking University Third HospitalCompletedShoulder; Dislocation, ChronicChina
-
AcuFocus, Inc.CompletedPresbyopiaSingapore, Germany, New Zealand, Australia, Austria, United Kingdom
-
AcuFocus, Inc.CompletedPresbyopiaUnited States
-
AcuFocus, Inc.Completed
-
AcuFocus, Inc.CompletedPresbyopiaSingapore, Philippines, Australia, Austria, France, Japan, Netherlands, New Zealand, Spain, Turkey
-
Cornea and Laser Eye InstituteActive, not recruiting
-
Allotex, Inc.WithdrawnHyperopiaAustria, Belgium, France, Ireland, Switzerland, United Kingdom
-
ReVision Optics, Inc.UnknownPresbyopia | PseudophakiaUnited States